|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1022795050 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
180210s2016 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d MERUC
|d OCLCQ
|d REDDC
|d OCLCF
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9781118960141
|
| 020 |
|
|
|a 1118960149
|
| 035 |
|
|
|a (OCoLC)1022795050
|
| 050 |
|
4 |
|a RA643
|b .D435 2018
|
| 082 |
0 |
4 |
|a 616.9
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Kong, Nan.
|
| 245 |
1 |
0 |
|a Decision Analytics and Optimization in Disease Prevention and Treatment.
|
| 260 |
|
|
|a Somerset :
|b John Wiley & Sons, Incorporated,
|c 2016.
|
| 300 |
|
|
|a 1 online resource (462 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro; TITLE PAGE; TABLE OF CONTENTS; CONTRIBUTORS; PREFACE; PART 1: INFECTIOUS DISEASE CONTROL AND MANAGEMENT; 1 OPTIMIZATION IN INFECTIOUS DISEASE CONTROL AND PREVENTION; 1.1 TUBERCULOSIS EPIDEMIOLOGY AND BACKGROUND; 1.2 MICROSIMULATIONS FOR DISEASE CONTROL; 1.3 A MICROSIMULATION FOR TUBERCULOSIS CONTROL IN INDIA; 1.4 CONCLUSION; REFERENCES; 2 SAVING LIVES WITH OPERATIONS RESEARCH; 2.1 INTRODUCTION; 2.2 HIV RESOURCE ALLOCATION: THEORETICAL ANALYSES; 2.3 HIV RESOURCE ALLOCATION: PORTFOLIO ANALYSES; 2.4 HIV RESOURCE ALLOCATION: A TOOLFOR DECISION MAKERS; 2.5 DISCUSSION AND FURTHER RESEARCH.
|
| 505 |
8 |
|
|a ACKNOWLEDGMENTREFERENCES; 3 ADAPTIVE DECISIONâ#x80;#x90;MAKING DURING EPIDEMICS; 3.1 INTRODUCTION; 3.2 PROBLEM FORMULATION; 3.3 METHODS; 3.4 NUMERICAL RESULTS; 3.5 CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; 4 ASSESSING REGISTERâ#x80;#x90;BASED CHLAMYDIA INFECTION SCREENING STRATEGIES; 4.1 Introduction; 4.2 BACKGROUND LITERATURE REVIEW; 4.3 MATHEMATICAL MODELING; 4.4 STRATEGY ASSESSMENT; 4.5 CONCLUSIONS AND FUTURE RESEARCH; REFERENCES; 5 OPTIMAL SELECTION OF ASSAYS FOR DETECTING INFECTIOUS AGENTS IN DONATED BLOOD; 5.1 INTRODUCTION AND CHALLENGES; 5.2 THE NOTATION AND DECISION PROBLEM.
|
| 505 |
8 |
|
|a 5.3 THE CASE STUDY OF THE SUBâ#x80;#x90;SAHARAN AFRICA REGION AND THE UNITED STATES5.4 CONTRIBUTIONS AND FUTURE RESEARCH DIRECTIONS; ACKNOWLEDGMENTS; REFERENCES; 6 MODELING CHRONIC HEPATITIS C DURING RAPID THERAPEUTIC ADVANCE; 6.1 INTRODUCTION; 6.2 METHOD; 6.3 FOUR RESEARCH AREAS IN DESIGNING EFFECTIVE HCV INTERVENTIONS; 6.4 CONCLUDING REMARKS; REFERENCES; PART 2: NONCOMMUNICABLE DISEASE PREVENTION; 7 MODELING DISEASE PROGRESSION AND RISKâ#x80;#x90;DIFFERENTIATED SCREENING FOR CERVICAL CANCER PREVENTION; 7.1 INTRODUCTION; 7.2 LITERATURE REVIEW; 7.3 MODELING CERVICAL CANCER SCREENING.
|
| 505 |
8 |
|
|a 7.4 MODELâ#x80;#x90;BASED ANALYSES7.5 CONCLUDING REMARKS; REFERENCES; 8 USING FINITEâ#x80;#x90;HORIZON MARKOV DECISION PROCESSES FOR OPTIMIZING POSTâ#x80;#x90;MAMMOGRAPHY DIAGNOSTIC DECISIONS; 8.1 INTRODUCTION; 8.2 MODEL FORMULATIONS; 8.3 STRUCTURAL PROPERTIES; 8.4 NUMERICAL RESULTS; 8.5 SUMMARY; ACKNOWLEDGMENTS; REFERENCES; 9 PARTIALLY OBSERVABLE MARKOV DECISION PROCESSES FOR PROSTATE CANCER SCREENING, SURVEILLANCE, AND TREATMENT; 9.1 INTRODUCTION; 9.2 REVIEW OF POMDP MODELS AND BENCHMARK ALGORITHMS; 9.3 A POMDP MODEL FOR PROSTATE CANCER SCREENING, SURVEILLANCE, AND TREATMENT; 9.4 BUDGETED SAMPLING APPROXIMATION.
|
| 505 |
8 |
|
|a 9.5 COMPUTATIONAL EXPERIMENTS9.6 CONCLUSIONS; REFERENCES; 10 COSTâ#x80;#x90;EFFECTIVENESS ANALYSIS OF BREAST CANCER MAMMOGRAPHY SCREENING POLICIES CONSIDERING UNCERTAINTY IN WOMENâ#x80;#x99;S ADHERENCE; 10.1 INTRODUCTION; 10.2 MODEL FORMULATION; 10.3 NUMERICAL STUDIES; 10.4 RESULTS; 10.5 SUMMARY; REFERENCES; 11 AN AGENTâ#x80;#x90;BASED MODEL FOR IDEAL CARDIOVASCULAR HEALTH; 11.1 INTRODUCTION; 11.2 METHODOLOGY; 11.3 RESULTS; 11.4 SIMULATING THE MEDICAREâ#x80;#x90;AGE POPULATION AND THE DISEASEâ#x80;#x90;SPECIFIC SUBPOPULATIONS; 11.5 FUTURE RESEARCH; 11.6 SUMMARY; REFERENCES; PART 3: TREATMENT TECHNOLOGY AND SYSTEM.
|
| 505 |
8 |
|
|a 12 BIOLOGICAL PLANNING OPTIMIZATION FOR HIGHâ#x80;#x90;DOSEâ#x80;#x90;RATE BRACHYTHERAPY AND ITS APPLICATION TO CERVICAL CANCER TREATMENT.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Communicable Disease Control.
|
| 650 |
|
0 |
|a Decision making.
|
| 650 |
|
0 |
|a Preventive health services.
|
| 650 |
|
2 |
|a Decision Making
|
| 650 |
|
6 |
|a Prise de décision.
|
| 650 |
|
6 |
|a Soins médicaux préventifs.
|
| 650 |
|
7 |
|a decision making.
|2 aat
|
| 650 |
|
7 |
|a Decision making
|2 fast
|
| 650 |
|
7 |
|a Preventive health services
|2 fast
|
| 700 |
1 |
|
|a Zhang, Shengfan.
|
| 758 |
|
|
|i has work:
|a Decision analytics and optimization in disease prevention and treatment (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCH3RtyX3KXfDkBHMDxrtjy
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Kong, Nan.
|t Decision Analytics and Optimization in Disease Prevention and Treatment.
|d Somerset : John Wiley & Sons, Incorporated, ©2016
|z 9781118960127
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5261498
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL5261498
|
| 994 |
|
|
|a 92
|b IZTAP
|
